Literature DB >> 25801716

[Cardiac resynchronisation with atrial sensing: Is it feasible?].

Barbara Bellmann1, V Tscholl, U Landmesser, M Roser.   

Abstract

In this article the cases of two female patients with heart failure (functional class III) and an intrinsic complete left bundle branch block are reported. Both patients have had an implanted cardioverter defibrillator (ICD) connected to a VDD lead for primary prevention of sudden cardiac death. Atrial sensing was good/acceptable with a physiological frequency histogram and normal PQ time. A system upgrade to cardiac resynchronization therapy device (CRT) was planned. The VDD lead was directly connected to the Bivent ICD. The follow up showed stable measurements and a high biventricular pacing rate. Thus, usage of VDD leads for atrial sensing in CRT seems to be possible in a selected patient population.

Entities:  

Mesh:

Year:  2015        PMID: 25801716     DOI: 10.1007/s00399-015-0361-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  3 in total

1.  Heart rate turbulence and heart rate variability in patients with atrial synchronous ventricular pacing.

Authors:  Harun Kilic; Ozlem Karakurt; Ramazan Akdemir; Mehmet Dogan; Asuman Bicer; Sadik Acikel; Goksel Cagirci; Huseyin Gunduz
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

2.  Risk factors influencing complications of cardiac implantable electronic device implantation: infection, pneumothorax and heart perforation: a nationwide population-based cohort study.

Authors:  Yu-Sheng Lin; Sheng-Ping Hung; Pei-Rung Chen; Chia-Hung Yang; Hung-Ta Wo; Po-Cheng Chang; Chun-Chieh Wang; Chung-Chuan Chou; Ming-Shien Wen; Chang-Ming Chung; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

3.  Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study.

Authors:  Giovanni B Forleo; Luigi Di Biase; Rupinder Bharmi; Nirav Dalal; Germana Panattoni; Annalisa Pollastrelli; Manfredi Tesauro; Luca Santini; Andrea Natale; Francesco Romeo
Journal:  Europace       Date:  2014-11-04       Impact factor: 5.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.